Thoughts on Joining Foresite Labs by Uplaksh Kumar

BIOS Builders Interview with Mark Chao, Co-founder & CEO at TenSixteen Bio

Foresite Labs’ new $173M fund to bankroll fewer startups but ‘big ideas’ fueled by data

Foresite Capital Launches $173M Fund to Support Incubated Companies

With Forty Seven co-founder at the helm, new biotech spinout launches to target mutations potentially linked to numerous diseases

TenSixteen Bio Launches With $40M Series A To Advance A New Approach To Disease Detection And Treatment

Foresite Labs Hatches Big-Data-Driven Companies Destined to Shake up Healthcare

Seven Biopharma Trends to Watch in 2022

Foresite’s immunology play gets a $200M megaround for TYK2 program, rebranding as Alumis

Top Life Sciences Startups to Watch in 2022